Total Funding
73
47
Total FundingSeries B raised
Growth Score 73 in past quarter
-3 pts
Heat Score 47 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36760
A UK-based developer of drugs to treat respiratory diseases
Martin Gosling: CSO- Peter Finan: Enterprise Therapeutics
About the Company
Enterprise Therapeutics is a drug discovery company dedicated to the research
and development of novel therapies for the treatment of respiratory diseases.
In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying
mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
